Osteoprotegerin Gene as a Biomarker in the Development of Osteoporosis in Postmenopausal Women
Osteoporosis is a multifactorial and polygenic disease caused by an imbalance between osteoclastogenesis and osteoblastogenesis, leading to a decrease in bone mineral density and the occurrence of disorders in the microarchitecture and metabolism of bone tissue. In postmenopausal women, there is a s...
Main Authors: | Filip Przerwa, Izabela Uzar, Anna Bogacz, Katarzyna Kotrych, Tadeusz Sulikowski, Marlena Wolek, Adam Kamiński, Paweł Ziętek, Bogusław Czerny |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/12/3218 |
Similar Items
-
Osteoporosis and polymorphisms of osteoprotegerin gene in postmenopausal women – a pilot study
by: Selma Cvijetic, et al.
Published: (2016-03-01) -
Functionalized calcium phosphate nanoparticles to direct osteoprotegerin to bone lesion sites in a medaka (Oryzias latipes) osteoporosis model
by: Nurgul Imangali, et al.
Published: (2023-02-01) -
Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway
by: Xiao-Feng He, et al.
Published: (2017-11-01) -
Role of Serum Osteoprotegerin as a Diagnostic Indicator of Primary Osteoporosis in Perimenopausal and Postmenopausal Women: An Indian Perspective
by: Pandey A, et al.
Published: (2018-03-01) -
Evaluation of rs3102735 and rs2073617 Osteoprotegerin Gene Polymorphisms and the Risk of Childhood Acute lymphoblastic Leukemia in Zahedan Southeast Iran
by: Mohammad Hashemi, et al.
Published: (2014-12-01)